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Abstract
Background: Many efforts have been made to understand basal mechanisms of mycobacterial infections. Macrophages are
the first line of host immune defence to encounter and eradicate mycobacteria. Pathogenic species have evolved different
mechanisms to evade host response, e.g. by influencing macrophage apoptotic pathways. However, the underlying
molecular regulation is not fully understood. A new layer of eukaryotic regulation of gene expression is constituted by
microRNAs. Therefore, we present a comprehensive study for identification of these key regulators and their targets in the
context of host macrophage response to mycobacterial infections.
Methodology/Principal Findings: We performed microRNA as well as mRNA expression analysis of human monocyte
derived macrophages infected with several Mycobacterium avium hominissuis strains by means of microarrays as well as
quantitative reverse transcription PCR (qRT-PCR). The data revealed the ability of all strains to inhibit apoptosis by
transcriptional regulation of BCL2 family members. Accordingly, at 48 h after infection macrophages infected with all M.
avium strains showed significantly decreased caspase 3 and 7 activities compared to the controls. Expression of let-7e, miR-
29a and miR-886-5p were increased in response to mycobacterial infection at 48 h. The integrated analysis of microRNA and
mRNA expression as well as target prediction pointed out regulative networks identifying caspase 3 and 7 as potential
targets of let-7e and miR-29a, respectively. Consecutive reporter assays verified the regulation of caspase 3 and 7 by these
microRNAs.
Conclusions/Significance: We show for the first time that mycobacterial infection of human macrophages causes a specific
microRNA response. We furthermore outlined a regulatory network of potential interactions between microRNAs and
mRNAs. This study provides a theoretical concept for unveiling how distinct mycobacteria could manipulate host cell
response. In addition, functional relevance was confirmed by uncovering the control of major caspases 3 and 7 by let-7e and
miR-29a, respectively.
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Introduction
Mononuclear phagocytes represent gateways of the host
immune system for encountering and eliminating pathogens.
However, various disease agents have evolved efficient strategies to
overcome this fundamental mechanism of the innate immunity.
For example, the genus Mycobacterium comprises highly pathogenic
species but also opportunists such as M. avium, which are able to
withstand the hostile phagosomal environment and cause
disseminated infections. Mycobacterial infections of humans and
animals give cause for serious concern. In this regard, tuberculosis
remains one of the major threats to humans still possessing a high
mortality rate. But also less pathogenic mycobacteria e.g. members
of the M. avium complex (MAC) are able to cause disseminated
infections in immuno-compromised persons such as AIDS patients
[1]. MAC furthermore elicits lymphadenopathies in otherwise
healthy children and pneumonia in persons with pre-disposing
lung conditions [2,3]. MAC comprises the species M. intracellulare
and M. avium. The latter is divided into four subspecies: M. avium
subsp. hominissuis (MAH), M. avium subsp. avium (MAA), M. avium
subsp. silvaticum (MAS) and M. avium subsp. paratuberculosis (MAP).
Human mycobacteriosis is predominantly caused by MAH, while
MAA and MAS affect primarily birds [4] and MAP is the
causative agent of Johne’s disease.
M. avium is phagocytosed by macrophages after binding to the
CR3 complement receptor, the vitronectin receptor, the mannose
receptor, CD14, CD43 and Toll-like receptors (TLR) [5,6].
Recognition of M. avium by TLR2 and TLR4 initiates a MyD88-
dependent activation of antibacterial effector mechanisms [6,7]. In
monocyte derived macrophages (MDMs) both TLR2 and TLR4
induce e.g. tyrosine phosphorylation of phospholipase C gamma 2
(PLCG2) causing the release of Ca
2+ and production of pro-
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Nonetheless, M. avium is able to inhibit the phagosome-lysosome-
fusion and to replicate within macrophages. Survival of M. avium
within phago-lysosomes of macrophages may be explained by
reduced response to interferon gamma (IFNG) upon infection.
This may result from up-regulation of the suppressors of cytokine
signalling (SOCS) upon interaction of macrophage receptors with
M. avium. Increased SOCS1 and SOCS3 expression was
demonstrated as early as two hours after infection of macrophages
with M. avium [9]. Virulent strains of M. avium activate
macrophages to a lower degree compared to non-virulent strains
[10]. Interestingly, pronounced interleukin (IL) 12 expression was
shown after infection with non-virulent strains. It was suggested
that virulence could be considered as the intrinsic inability of
certain isolates to activate macrophages. Moreover, it was shown
that infection of human MDMs with M. avium causes an early
response (after 2 h) of signalling molecules and transcription
factors including the mitogen-activated protein kinase (MAPK)
pathway. Also NFkB mediated pro-inflammatory response is
triggered early after M. avium infection together with up-regulation
of several matrix metalloproteinases (MMPs), which also possess
increased expression after 24 h infection. The NFkB activation
together with increased expression of TNF and IL1B drive a pro-
inflammatory response to combat M. avium, while early but non-
sustained IL10 and transforming growth factor beta (TGFB)
expression seem to weaken this effect [6]. TNF and IL1B exert
pro-inflammatory effects such as recruitment of neutrophils,
activation of monocytes or induction of endothelial adhesion
molecules. It was however shown that IL10 production in
macrophages infected with M. avium results in inhibition of TNF
mediated apoptosis [11]. Apoptosis appears after TNF mediated
activation of the extrinsic pathway leading to caspase 8 (CASP8)
activation. Concomitant permeabilisation of the mitochondrial
membrane activates the intrinsic apoptotic pathway. Both
pathways result in CASP3 activation and induction of apoptosis
[12,13]. Programmed cell death of infected host cells is an archaic
mechanism of the immune system to eradicate pathogens. Behar
and colleagues (2010) reviewed that attenuated M. tuberculosis
induces macrophage apoptosis while virulent strains inhibit
apoptosis and induce necrosis. The latter is a characteristic being
absent in non-pathogenic mycobacteria. Apoptosis of infected
macrophages is associated with diminished pathogen viability and
has the benefit for the host to constrain the infection, to minimise
tissue injury and can promote cross-priming. On the other hand,
inhibition of cell death allows the pathogen to evade humoral
immunity and provides time for the pathogen to replicate [12].
A number of studies have reported differential gene expression
of macrophages upon infection with M. avium [6,10,14]. In
general, regulated genes were involved in production of cytokines,
lymphokines, chemokines, in adhesion, signal transduction,
transcription, protein cleavage and actin polymerisation. Recent
studies have indicated that many of the mentioned signalling
molecules are under the control of microRNAs (miRNAs).
MiRNAs belong to the class of regulating small non-coding RNAs
directing mRNA degradation following deadenylation or transla-
tional repression. Current research on miRNAs has unveiled a
new layer of eukaryotic gene expression regulation unravelling
several unsolved biological mechanisms in development or disease.
MiRNAs act as major regulators of developmental timing, cellular
differentiation, signalling pathways but also apoptosis [15]. Both
the extrinsic as well as the intrinsic apoptotic pathways are
regulated by miRNAs. In this context, the pro-survival factor
BCL2 belonging to the intrinsic pathway was reported to be
targeted by miR-15 and miR-16, while miR-221 and miR-222
affect the extrinsic apoptotic pathway [16]. But also let-7a was
shown to inhibit apoptosis by targeting the executioner of
programmed cell death CASP3 [17]. Studies have shown that
innate as well as adaptive immune cells possess specific miRNA
expression patterns regulating both cell fate and function [18].
MiRNAs not only regulate early haematopoietic cell development
but also direct the differentiation of common myeloid progenitor
cells into different myeloid cell types. For example, monocyte,
macrophage and dendritic cell (DC) development is regulated by
miRNAs. Granulocyte-monocyte progenitors derive from com-
mon myeloid progenitors to produce neutrophils and monocytes.
The latter can differentiate to macrophages or DCs. This process
is initiated by decreased expression of the members of the miR-17-
92 cluster leading to the depression of the transcription factor
RUNX1 promoting monocyte differentiation. On the other hand,
macrophages encountering pathogens respond with up-regulation
of e.g. miR-155 or and miR-146. This response is triggered by
TLR signalling as well as pro-inflammatory cytokines e.g. TNF by
activating the transcription factors AP1 and NFkB. Pro-inflam-
matory cytokines are key molecules of pathogen eradication,
however their excessive production leads to tissue damage. The
role of miRNAs in the macrophage inflammatory response seems
to be the boost of a sharp and intense reaction towards eradication
of pathogens while avoiding excessive damage by realising a
negative feedback loop [18]. During the macrophage inflamma-
tory response miR-155 targets for example SOCS1 and SHIP1,
both negative regulators of TLR signalling. On the other hand
convergent expression of miR-146 affects downstream TLR
signalling molecules such as interleukin-1 receptor-associated
kinase (IRAK) 1 and 2 or TNF receptor-associated factor (TRAF)
6, which promote inflammation [18].
Many efforts have recently been made to understand the role of
miRNAs in innate immunity and in macrophage inflammatory
response to pathogens. The particular nature of the macrophage
response to Mycobacterium infections motivated us to perform an
integrated analysis of miRNAs and mRNAs upon infection of
human MDMs. Based on the growing number of studies showing
that miRNAs rather direct mRNA degradation than translational
repression, bioinformatic tools e.g. MAGIA [19] or MMIA [20]
were developed to facilitate the detection of functional miRNA-
mRNA-interactions in different contexts. For our analysis, we used
two MAH strains (originally isolated from human patients) to
perform microarray experiments. We extended our investigations
by qRT-PCR analysis and by using an additional MAH strain
isolated from water. These strains were used for infection
experiments with macrophages derived from buffy coats of three
independent donors. Taken together, our data show for the first
time that miRNAs respond specifically to mycobacterial infections
compared to the control E. coli K12. We furthermore provide an
analytical concept for dissecting the host response upon pathogen
interaction. We show that inhibition of apoptosis after mycobac-
terial infection is directed via CASP3 and 7 down-regulation
mediated by let-7e and miR-29a, respectively.
Results
For performing the microarray based integrated analysis of
mRNA and miRNA data, we chose two MAH strains being
originally isolated from human patients, each as an representative
for the causative agent of disseminated infections in AIDS patients
or lymphadenitis, respectively. MAH strain 104 was isolated from
an AIDS patient [21] and its genome is entirely sequenced. MAH
strain 10091/06 was isolated from the lymph node of an infected
child. MDMs used for infection experiments were enriched from
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amounted to around 70% as evaluated after detection of the
CD14
+ population by means of FACS analysis. Each infection was
performed independently with MDMs from three different donors.
For both, detection of mRNAs as well as miRNAs by means of
microarray analysis, pools of total RNA from these three
experiments were prepared for each MAH strain and non-infected
controls at 6, 24 and 48 h post infection (p.i.). To verify linear
amplification of pooled RNA used for cDNA microarrays, we
determined the Pearson correlation coefficient (Pearson r) of five
randomly selected genes (ACTB, BCL2, GAPDH, TNF and
TP53) by performing qRT-PCR reactions before and after RNA
amplification. For all selected genes we obtained clear linearity
with Pearson r ranging between 0.87 (ACTB) and 0.99 (TNF) with
two-tailed P values#0.002.
Microarray study of infected MDMs reflects a comparable
response to MAH as to other virulent mycobacteria
To assess the expression patterns of immuno- as well as
apoptosis-related genes affected by MAH infection, we first
regarded genes showing consistent and at least 2-fold (mean) up-
and down-regulation upon infection by both MAH strains. As
shown in figure 1 A, this analysis revealed 36 genes possessing 2- to
39-fold (median of all time points) increased expression upon
infection, while 10 mRNAs were 2- to 3-fold down-regulated. To
provide a more in depth insight into the data, mRNAs showing at
least 2-fold up- or down-regulation over all time points are
summarised in table 1, including those showing expression signals
in at least 4 out of 6 samples. Since we did not observe any
systematic and strain specific difference in the MDM response to
MAH infection, further analysis was performed considering the
entire data in a time specific manner. Genes showing significantly
differential expression regarding all time points after infection were
identified by the analysis of variance (ANOVA). Hereby, we were
able to identify two distinct groups of genes showing an initial
response of either increased (figure 1 B) or decreased (figure 1 C)
expression compared to the non-infected controls, respectively.
These expression patterns presumably reflected a temporal
regulation of early or late responsive genes in the context of
MAH infection.
The identified clusters presented above, which were either
dysregulated among all time points (figure 1 A) or possessed a
temporal dysregulation (figure 1 B and C) were chosen for
pathway analysis using the Cytoscape [22] plug-in ClueGO [23].
For this purpose, we added also genes to the cluster shown in
figure 1 A that did not exhibit consistent expression on all
microarrays. Pathways showing functional enrichment are shown
in table 2 together with involved and differentially expressed
genes. Affected pathways reflect many well described functional
processes involved in mycobacterial interference with the host
response. It is known that pathogenic mycobacteria promote
intracellular survival in macrophages by affecting phagosome-
lysosome-fusion, antibacterial responses involving for example
Ca
2+ signalling, PI3K, JAK/STAT, MAPK and TLR pathways as
well as apoptosis. The microarray data presented in this study
indicated regulated expression of various genes involved in
signalling pathways mentioned above.
An initial process with a potential role in affecting intracellular
survival is the internalisation of mycobacteria by macrophages.
This is mediated by phagocytic receptors including Fc-gamma
receptor (FCGR), complement receptors (CR) of the integrin
family (ITG) and mannose receptors (MRC). Indications of
involvement of those signalling events are reflected in table 2.
Accordingly, differential expression of FCGR1A and FCGR2 was
detected as shown in figure 1 B, while expression signals for
FCER2 were below detection limit of the applied method. More
precisely, FCGR1A showed more than 3-fold reduced expression
levels for both MAH strains at 6 h p.i. Furthermore, most
members of the integrin family were down-regulated at the same
time (ITGAM, ITGAX, ITGB2, data not shown). MRC1 showed
2- to 5-fold increased expression at 24 and 48 h p.i. (table 1).
After internalisation, phagosomal maturation events take place,
which involve fusion of various vesicles and formation of phago-
lysosomes. Phagosomal markers include lysosome-associated
membrane proteins LAMP1 and LAMP2 and acid hydrolases
like cathepsin D (CTDS) and sytaxin 3 (STX3). Pathogenic
mycobacteria further have been shown to interfere with Ca
2+ and
PI3K signalling pathways, which are essential for phagosomal
maturation and involve calmodulin (CALM2) activation. Our data
reflected a consistent 2-fold (median) down-regulation of CALM2
at all time points, markedly reduced STX3 expression at 48 h p.i.
(data not shown) and decreased CTSD (Fig. 1C) mRNA at 6 h p.i.
LAMP1 and LAMP2 expression was down-regulated at 6 h or
48 h p.i., respectively (data not shown).
When invading bacteria are detected by the host, the activation
of signalling pathways like JAK/STAT and MAPK pathways lead
to a release of pro-inflammatory cytokines. JAK/STAT signalling
is induced after binding of IFNG to its receptors (IFNGRs),
whereas SOCS directly bind JAKs and inactivate JAK/STAT
signalling. Accordingly, in our study IFNGR1 expression was 1.7-
fold reduced at 6 h p.i. (figure 1 B). Additionally, we observed an
initial 3.6-fold reduced STAT1 expression early after infection (6 h
p.i.), while expression was up to 2-fold increased after 24 h and
48 h (figure 1 B). Further, our data reflected an averaged 3.8-fold
up-regulation of SOCS3 at all time points (table 1). In the context
of interfering with MAPK signalling, we observed a regulation of
PLCG2 as illustrated in figure 1 B. A pronounced down-regulation
of PLCG2 was observed, showing 2.4-fold reduced expression
early after MAH infection (6 h p.i.). TLRs and CD40 (TNFRSF5)
were reported not to be implicated in the uptake of M. tuberculosis
but mediate signalling events upon activation [24]. TLR activation
typically induces NFkB and MAPK pathways resulting in the
production of pro-inflammatory cytokines. According to our
microarray study, at 48 h p.i. TLR4, TRAF6 and MyD88 were
transcriptionally down-regulated upon M. avium infection (data not
shown). Furthermore, TLR2 was up-regulated at 24 and 48 h p.i.
(figure 1 B), while CD40 showed 2.6-fold (mean) increased
expression at all time points (figure 1A).
As mentioned above, the activation of macrophages upon
mycobacterial infection leads to an innate immune response.
Innate immunity is linked to production of pro-inflammatory
cytokines. Furthermore, in response to pathogens macrophages
are functionally polarised and can be broadly classified into two
groups: M1 and M2. Put simply, M1 macrophages show
microbicidal and inflammatory character, while M2 macrophages
are immunomodulators and poorly microbicidial [25]. Both
possess characteristic gene expression profiles of e.g. ILs, TGFB,
VEGF, MMPs, CXCL10 or TNF. These genes also show
regulated expression in the presented study as follows. Our
microarray data showed strong up-regulation of IL1B (23-fold),
IL8 (5.3-fold) and IL10 (3.7-fold) at all time points and in both
MAH strains (figure 1 A, table 1). IL7R showed an identical
pattern of averaged 8-fold up-regulation (table 1), except at 48 h
p.i., when the expression value for MAH 104 was not detected in
the microarray experiments. IL3RA showed time-dependent
regulation with reduced expression at 6 h p.i. and up-regulation
at 24 h and 48 h (figure 1 B, table 1). IL18BP was down-regulated
at all time points and in both MAH strains (figure 1 A, table 1).
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MAH 10091/06 infected MDMs and showed consistent up-
regulation (data not shown). This is also true for IL15 at 6 h and
24 h after infection (data not shown). In the context of
macrophage polarisation, we further observed a 14-fold induced
expression of VEGFC, one of several isoforms of VEGF, and a
2.3- to 16-fold induced expression of several MMPs (MMP1,
MMP3, MMP10, and MMP14) averaged over all time points and
MAH strains (table 1, figure 1 A). The described patterns point to
a M2 polaraisation. However, CXCL10 was 2-fold up-regulated at
all time points (mean value, table 1) and TNF showed 6.7-fold
elevated transcript levels at all time points (mean value, figure 1 A,
table 1) both representing M1 polarisation of macrophages.
TGFB1 showed induced expression after 24 h p.i. (figure 1 B).
Many pathogens influence host apoptotic pathways [26]. Various
indications for altered apoptotic signalling are reflected by the
microarray data presented here. Stimulation of Ca
2+ signalling
facilitates apoptosis by increasing the permeability of mitochondrial
Figure 1. Heatmaps of mRNA expression data of MAH infected MDMs after microarray analysis. Columns represent temporal expression
of MDMs at 6, 24 and 48 h p.i. with MAH strains 10091/06 and 104. Colours represent log 2 ratios of the infected cells versus the non-infected control
according to the scales shown below. Samples represent a pool of three independent infection experiments. Panel A shows 36 genes possessing 2- to
39-fold (median of all time points) increased expression upon infection, while 10 genes were 2- to 3-fold down-regulated. Panel B and C illustrate
mRNAs being temporally induced or repressed after infection. Panel D reflects dysregulated miRNAs after infection, while panel E shows temporally
induced miRNAs. An averaged trace of the expression profile is integrated as a white graph by the acuity software (Panel B, C and E). Underlined
mRNAs and miRNAs are addressed in the results section.
doi:10.1371/journal.pone.0020258.g001
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Gene Symbol Gene Desciption Log 2 Ratio*
INHBA inhibin, beta A 5.3
CCL1 chemokine (C-C motif) ligand 1 5.1
IL1B interleukin 1, beta 4.5
VEGFC vascular endothelial growth factor C 4.0
MMP3 matrix metallopeptidase 3 (stromelysin 1, progelatinase) 3.7
SLAMF1 signaling lymphocytic activation molecule family member 1 3.6
CCR7 chemokine (C-C motif) receptor 7 3.3
MMP1 matrix metallopeptidase 1 (interstitial collagenase) 3.3
TNFAIP6 tumor necrosis factor, alpha-induced protein 6 3.3
TNIP3 ABIN-3, LIND; TNFAIP3 interacting protein 3 3.2
CCL20 chemokine (C-C motif) ligand 20; K05514 C-C motif chemokine, other 3.2
IL7R interleukin 7 receptor; K05072 interleukin 7 receptor 3.0
PROCR protein C receptor, endothelial; K06557 protein C receptor, endothelial (EPCR) 3.0
PDGFB platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) 2.9
CSF2 colony stimulating factor 2 (granulocyte-macrophage) 2.8
TNF tumor necrosis factor 2.8
CCL3-CCL3L1-CCL3L3 chemokine (C-C motif) ligand 3 - chemokine (C-C motif) ligand 3-like 1 - chemokine (C-C motif) ligand 3-like 3 2.5
IL8 interleukin 8; K10030 interleukin 8 2.4
IL3RA IL3RA, CD123, IL3R, IL3RAY, IL3RX, IL3RY, MGC34174, hIL-3Ra; interleukin 3 receptor, alpha (low affinity 2.4
BMP6 BMP6, VGR, VGR1; bone morphogenetic protein 6; K04663 bone morphogenetic protein 5/6/7/8 2.4
MSC musculin (activated B-cell factor-1) 2.3
CCL4-CCL4L2-CCL4L1 chemokine (C-C motif) ligand 4 - chemokine (C-C motif) ligand 4-like 2 - chemokine (C-C motif) ligand 4-like 1 2.3
TM4SF1 transmembrane 4 L six family member 1 2.3
TNFRSF9 tumor necrosis factor receptor superfamily, member 9 2.3
MRC1 mannose receptor, C type 1 2.3
LAMB3 laminin, beta 3; K06244 laminin, beta 3 2.2
TNFRSF19 tumor necrosis factor receptor superfamily, member 19 2.2
CCL5 RANTES, chemokine (C-C motif) ligand 5 2.1
CHST2 GST2, carbohydrate (N-acetylglucosamine-6-O) sulfotransferase 2 2.0
ETS2 v-ets erythroblastosis virus E26 oncogene homolog 2 (avian 2.0
TNFSF9 CD137L; tumor necrosis factor (ligand) superfamily, member 9 2.0
CCL18 AMAC1, MIP-4, chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) 2.0
PTGS2 COX2, prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) 1.9
IL10 interleukin 10 1.9
SOCS3 suppressor of cytokine signaling 3 1.9
SERPINB2 serpin peptidase inhibitor, clade B (ovalbumin) 1.8
SERPINE1 PAI, serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 1.8
TIMP1 metallopeptidase inhibitor 1 1.8
BTG1 B-cell translocation gene 1, anti-proliferative 1.8
SOD2 superoxide dismutase 2, mitochondrial 1.8
CD14 CD14 molecule 1.7
MMP10 matrix metallopeptidase 10 (stromelysin 2) 1.5
PLAUR plasminogen activator, urokinase receptor 1.5
NFKBIA nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha 1.4
CD40 TNFRSF5, CD40 molecule, TNF receptor superfamily member 5 1.3
MMP14 matrix metallopeptidase 14 (membrane-inserted) 1.3
IRF1 interferon regulatory factor 1 1.3
BIRC3 AIP, baculoviral IAP repeat-containing 3 1.2
ICAM1 CD54, intercellular adhesion molecule 1 1.2
Regulative Networks in Mycobacterial Infection
PLoS ONE | www.plosone.org 5 May 2011 | Volume 6 | Issue 5 | e20258membranes, thereby promoting the release of pro-apoptotic factors
such as cytochrome C. The microarray data of CALM2, STX3 and
CTSD regulation was already mentioned in the context of Ca
2+
signalling and phagosome maturation. Our data (table 2) further
reflected the extrinsic pathway, which involves activation of death
receptors and CASP8/10 and CASP3. In the microarray data
CASP3, 6 and 7 were down-regulated, with most pronounced
regulation at 48 h p.i. (figure 1 C or data not shown).
Down-regulation of caspases in infected MDMs suggested the
ability of MAH strains to inhibit apoptosis similar to other virulent
mycobacteria.
Identification of differentially expressed miRNAs and
regulative networks of MAH infection deduced from
integrated miRNA-mRNA microarray analysis
Contrary to a general induction of mRNA expression in MAH
infected cells, many of differentially regulated miRNAs showed
decreased expression upon MAH infection compared to the
controls (figure 1 D). However, miR-155, miR-146a, and miR-
886-5p were consistently at least 1.4-fold up-regulated upon MAH
infection. In the general context of pathogen interaction with
immune cells, this is the first study reporting miR-886-5p
induction at 48 h p.i. Also, a temporal induction of miRNAs
was found after microarray analysis (figure 1 E), which occurred
mainly after 24 h and persisted until the end of the infection
experiments. For example, miR-29a was induced after 48 h
possessing 1.5-fold increased expression compared to the non-
infected control. Interestingly, let-7e was reported to be involved
in macrophage response to LPS [27] and miR-146b is known to
target TLR signalling [18], and both were 1.8- and 1.7-fold up-
regulated after 48 h, respectively (figure 1 E).
As described in the previous section, our data comprised many
mRNAs and miRNAs possessing a negatively correlated expres-
sion. Some of these correlations are validated and published
interactions between miRNAs and their target mRNAs, however
many potential interactions are still to be discovered. Our aim was
to create a theoretical concept of an interacting network based on
linking miRNA and mRNA expression data to target prediction.
To facilitate the prediction of possible interactions from compre-
hensive data presented here, we have employed the integrative
analysis of target prediction as well as miRNA and mRNA
expression by using the tool MAGIA [19]. We first predicted
targets of all detected miRNAs using the combined PITA and
Target Scan analysis implemented in the MAGIA query (not
considering the expression data). The hereby identified target list
was initially subjected to pathway analysis using the Cytoscape
Plug-In ClueGO (table S1). It was intriguing to find out that
predicted targets of miRNAs were enriched in pathways being
mainly involved in cell death/apoptosis and immune signalling.
This very well reflected affected cellular processes determined by
mRNA expression analysis as described above (table 2). Subse-
quently, we performed the MAGIA analysis considering the
expression data of dysregulated mRNAs showing at least 2-fold
altered expression or a temporal expression pattern (figure 1 A–C)
and considering all detected miRNAs of corresponding samples,
Gene Symbol Gene Desciption Log 2 Ratio*
CD44 CD44 molecule 1.1
CDKN1B cyclin-dependent kinase inhibitor 1B (p27, Kip1) 1.1
BATF basic leucine zipper transcription factor, ATF-like; K09034 ATF-like basic leucine zipper transcriptional factor 1.1
CSF2RA GMCSFR, colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) 1.1
FCGR2A-FCGR2B-FCGR2C Fc fragment of IgG, low affinity IIa, receptor (CD32) - Fc fragment of IgG, low affinity IIb,
receptor (CD32) - Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)
1.1
CD82 KAI1, CD82 molecule, kangai 1 1.0
ITGA5 CD49e, integrin, alpha 5 (fibronectin receptor, alpha polypeptide) 1.0
CXCL10 chemokine (C-X-C motif) ligand 10 1.0
QSOX1 quiescin Q6 sulfhydryl oxidase 1 1.0
PIAS1 protein inhibitor of activated STAT, 1 21.0
PRKCB protein kinase C, beta 21.0
SMAD2 MADH2, SMAD family member 2, mothers against DPP 2/3 21.0
PARP1 poly (ADP-ribose) polymerase 1 21.0
CD9 MIC3, CD9 molecule 21.0
IL18BP interleukin 18 binding protein 21.1
NFATC3 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 21.1
CD52 CD52 molecule 21.1
LGALS3 GALBP, lectin, galactoside-binding, soluble, 3 21.1
CCNE1 cyclin E1 21.2
STMN1 stathmin 1 21.6
LTA4H leukotriene A4 hydrolase 21.7
CD36 CD36 molecule 21.7
*Binary log ratio of increased or decreased gene expression according to microarray analysis of MAH infected macrophages compared to non-infected controls. At least
2-fold (corresponding to Log 2 ratios of $1o r#21) altered expression of median of values for 6, 24 and 48 h, as well as MAH 10091/06 and MAH 104 was considered.
doi:10.1371/journal.pone.0020258.t001
Table 1. Cont.
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Functionally enriched Pathways* % of Genes** Associated Genes***
Fc Epsilon Receptor I Signaling in Mast Cells 20 BTK, JUN, LYN, MAPK3, PRKCB, SYK
Fc epsilon RI signaling pathway 12 BTK, CSF2, LYN, MAP2K3, MAPK3, PLCG2, PRKCB, SYK, TNF
Complement and coagulation cascades 9 C1QA, C3AR1, CD46, PLAU, PLAUR, SERPINE1
Toll-Like Receptor Pathway 19 CD14, JUN, MAP2K3, MYD88, NFKB1, NFKBIA, TLR2
Toll-like receptor signaling pathway 16 CCL5, CD14, CD40, CXCL10, IL1B, IL8, JUN, MAP2K3, MAP3K8, MAPK3, MYD88,
NFKB1, NFKBIA, STAT1, TLR2, TNF
Apoptosis 14 BID, BIRC3, CASP3, CASP6, CFLAR, FAS, IL1B, IL3RA, MYD88, NFKB1, NFKBIA, TNF
Apoptotic Signaling in Response to DNA Damage 24 BID, CASP3, CASP6, PARP1, STAT1
Caspase Cascade in Apoptosis 17 BIRC3, CASP3, CASP6, PARP1
FAS signaling pathway (CD95) 20 CASP3, CASP6, CFLAR, FAS, JUN, PARP1
p53 signaling pathway 10 BID, CASP3, CCNE1, CD82, CDKN1A, FAS, SERPINE1
ATM Signaling Pathway 21 BRCA1, JUN, NFKB1, NFKBIA
Free Radical Induced Apoptosis 44 IL8, NFKB1, SOD1, TNF
Induction of apoptosis through DR3 and DR4/5
Death Receptors
21 BID, CASP3, CASP6, CFLAR, NFKB1, NFKBIA
Influence of Ras and Rho proteins on G1 to S Transition 25 CCNE1, CDKN1B, MAPK3, NFKB1, NFKBIA, RHOA
Role of Mitochondria in Apoptotic Signaling 19 BID, BIRC3, CASP3, CASP6
NF-kB Signaling Pathway 18 MYD88, NFKB1, NFKBIA, TNF
NFkB activation by Nontypeable Hemophilus influenzae 33 IL1B, IL8, MAP2K3, MYD88, NFKB1, NFKBIA, TLR2, TNF
Cytokine-cytokine receptor interaction 11 CCL1, CCL18, CCL20, CCL22, CCL5, CCR1, CCR5, CCR7, CD40, CSF2, CSF2RA,
CXCL10, FAS, IFNGR1, IL10, IL1B, IL3RA, IL7R, IL8, INHBA, PDGFB, TNF, TNFRSF19,
TNFRSF9, TNFSF13, TNFSF13B, TNFSF9, VEGFB, VEGFC
Cytokines and Inflammatory Response 15 CSF2, IL10, IL8, TNF
Dendritic cells in regulating TH1 and TH2 Development 19 CD40, CSF2, IL10, TLR2
IL-2 Receptor Beta Chain in T cell Activation 15 CFLAR, FAS, MAPK3, SOCS3, SYK
T cell receptor signaling pathway 10 CSF2, IL10, JUN, MAP3K8, NFATC3, NFKB1, NFKBIA, RHOA, TNF
Cadmium induces DNA synthesis and proliferation
in macrophages
36 JUN, MAPK3, NFKB1, NFKBIA, TNF
Selective expression of chemokine receptors during T-cell
polarization
19 CCR1, CCR5, CCR7, CSF2, IFNGR1
B cell receptor signaling pathway 14 BTK, JUN, LYN, NFATC3, NFKB1, NFKBIA, PLCG2, PRKCB, SYK
Natural killer cell mediated cytotoxicity 9 BID, CASP3, CSF2, FAS, ICAM1, IFNGR1, MAPK3, NFATC3, PLCG2, PRKCB, SYK, TNF
fMLP induced chemokine gene expression in HMC-1 cells 16 MAP2K3, MAPK3, NFKB1, NFKBIA
TNF/Stress Related Signaling 21 JUN, MAP2K3, NFKB1, NFKBIA, TNF
TNFR1 Signaling Pathway 14 CASP3, JUN, PARP1, TNF
The 4-1BB-dependent immune response 29 JUN, NFKB1, NFKBIA, TNFRSF9, TNFSF9
Mechanism of Gene Regulation by Peroxisome Proliferators via
PPARa(alpha)
12 HSP90AA1, JUN, MAPK3, NFKBIA, TNF
Signal transduction through IL1R 24 IL1B, JUN, MAP2K3, MYD88, NFKB1, NFKBIA, TNF
MAPKinase Signaling Pathway 10 JUN, MAP2K3, MAP3K8, MAPK3, MAPK6, NFKB1, NFKBIA, STAT1
ECM-receptor interaction 9 CD36, CD44, CD47, ITGA5, ITGA6, ITGB3, ITGB5, LAMB3
Epithelial cell signaling in Helicobacter pylori infection 12 CASP3, CCL5, IL8, JUN, LYN, NFKB1, NFKBIA, PLCG2
Hematopoietic cell lineage 17 CD14, CD36, CD44, CD9, CSF2, CSF2RA, FCGR1A, IL1B, IL3RA, IL7R, ITGA5, ITGA6,
ITGB3, MME, TNF
Chaperones modulate interferon Signaling Pathway 24 IFNGR1, NFKB1, NFKBIA, TNF
Alzheimer’s disease 18 C1QA, CASP3, IL1B, MME, TNF
*Pathways containing at least 4 differentially expressed genes (or 8%). Underlined pathways are referred to in the results section.
**Percentage of the differentially expressed genes which share a pathway membership with regard to all pathway-associated genes according to Reactome/Biocarta
and Kegg pathway databases implemented in Cytoscape 2.7.0.
***Differentially expressed genes with shared pathway memberships. Differentially expressed genes with at least 1.5-fold altered expression compared to non-infected
control cells and having valid expression signals in at least 4 out of 6 microarray experiments were considered for pathway mapping. Genes showing temporal
expression pattern, as depicted in figure 1 B and C, were also included in the analysis.
doi:10.1371/journal.pone.0020258.t002
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target genes including the calculated correlation coefficients
(Pearson r). Negatively correlated miRNA-mRNA interactions
were visualised as a network using Cytoscape (figure 2). This
network gives for the first time a theoretical outline of the
concerted action of regulating miRNAs and their potential target
mRNAs in mycobacterial infection of macrophages.
To give an example, according to this analysis CD44 is targeted
by let-7e and respective expression profiles are negatively
correlated (r=20.85). Reflecting CD44 expression, we observed
a 3.2- or 4-fold induction at 6 h p.i. considering MAH 10091/06
and 104, respectively (figure 1 C, table 1). In MAH 10091/06
infected cells a gradual decline of CD44 expression is observed
towards the later time points, while after infection with MAH 104
a decline in expression is observed from 6 h to 24 h p.i. By
contrast, let-7e expression is increasingly induced during the
course of MAH infection (figure 1 E). In order to predict
functional relations and to simplify the vast number of interactions
shown in figure 2, identified target genes were aligned to pathway
databases as described above. Table 3 summarises the determined
interactions and potentially affected pathways using ClueGO
default settings. CASP3, CASP6 and BID that are involved in
induction of apoptosis through death receptors were identified as
potential targets of let-7, miR-26, miR-30 and miR-185. IL10, IL8
and MAP2K3 being involved in the NFkB mediated inflammatory
response were predicted to be regulated by let-7 and miR-20a.
The complex predicted interactions of miRNAs targeting
dysregulated genes (figure 2) puts further emphasis on our
hypothesis that expression and regulation of miRNAs upon
MAH infection orchestrates mechanisms promoting cell survival.
In order to perform a more detailed analysis of the regulation of
cell fate, we specifically regarded apoptosis related genes in further
experiments.
MAH strains are able to inhibit apoptosis
For focusing our investigation on identified pathways and to
validate microarray data, we performed qRT-PCR experiments
for mRNAs as well as miRNAs. The individual response of MDMs
from three independent donors was studied by additionally
implying another MAH strain (M. avium hominissuis 2514) that
was originally isolated from water as well as including the non-
pathogenic E. coli K12 as a control. Since M. avium hominissuis
occurs ubiquitously in soil and water, MAH 2514 was included to
evaluate potential differences between patient and environmental
isolates.
In order to assess the ability of MAH strains to inhibit apoptosis,
CASP3/CASP7 assays were performed. As shown in figure 3, at 6
and 24 h p.i. significantly decreased caspase activity was observed
in all infected samples compared to the non-infected controls.
However, at 48 h p.i. MDMs infected with all three MAH strains
showed significantly decreased caspase activity compared to the
non-infected as well as E. coli K12 stimulated controls (P,0.001,
paired t test), while no significant difference was detected between
the latter. Accordingly, lower caspase expression was detected in
qRT-PCR experiments (figure 4 A). Based on the observation that
the employed MAH strains are able to inhibit apoptosis, we
considered mainly genes in the qRT-PCR experiments being
relevant to apoptosis and cytokine-cytokine receptor interaction.
For visualisation of the comprehensive and individual expression
data of selected genes, heat maps of log 2 ratios of infected samples
and non-treated controls were created for each point in time. As
shown in figure 4 A, MAH infections caused a unique response of
MDMs compared to the E. coli K12 stimulation. The detailed
expression analysis of selected genes showed on the one hand some
donor specific differences in response to the MAH infection. For
example, all MAH strains caused increased expression of IFNGR1
in donor 2 right after 6 h compared to the other samples
(P,0.002, unpaired t test). The up-regulation of IFNGR1
appeared after 24 h in all samples followed by decreased
expression after 48 h only in donor 3. Accordingly, we observed
sustained and consistent induction of TNF receptor superfamily
(TNFRSF) 6 and TNFRSF10C after 24 h by all MAH strains in
donor 1 compared to the other donors (figure 4).
On the other hand, a mostly consistent reaction of each donor
to all three MAH strains was investigated, indicating marginal
differences between MAH strains in terms of immunogenicity.
While e.g. IL12B expression was increased right after infection
and throughout the entire experiment, IL10 and IL12A showed
lower expression in early infection stage compared to E. coli K12
stimulated MDMs (P,0.005, unpaired t test). PTPN2 a member
of the protein tyrosine phosphatase family that was reported to
regulate IFNG induced cytokine signalling [28] exhibited also
significantly lower expression after MAH exposition particularly
at 6 h p.i. (P,0.004, unpaired t test) but also up to 48 h (P,0.04,
unpaired t test) compared to E. coli K12. In order to investigate
the observed PLCG2 down-regulation in our microarray
experiments in more detail, we included also PLCG2 in our
qRT-PCR experiments. However, PLCG2 expression was
decreased at 6 h p.i. in all samples possessing no statistically
significant difference between samples (figure 4 A and B). In late
stages of infection (24 and 48 h p.i.) the pro-apototic gene
BNIP3L was down-regulated in response to all MAH infections
compared to E. coli K12 stimulation (P,0.05, unpaired t test).
Another apoptotic activator BCL2L11 was significantly down-
regulated right after MAH infection and showed sustained and
decreased expression along the entire experiment compared to E.
coli K12 (P#0.01, unpaired t test). On the other hand, in later
infection stages BCL2L1, a pro-survival member of the BCL2
family, showed consistently decreased expression in E. coli K12
compared to MAH infected MDMs (P,0.015, unpaired t test).
Surprisingly, while E. coli K12 induced pronounced up-regulation
of the pro-apoptotic gene PMAIP1 at 6 h p.i. all three donors
responded on average with 8 times lower PMAIP1 expression to
MAH infection (P,0.0001, unpaired t test). At this point in time
MAH infection caused a balanced expression of PMAIP1 in
donor 1 compared to the non-infected control, while the other
two donors showed even down-regulation of PMAIP1 upon
MAH infection. Another BCL2 family member, BAX, acts as an
apoptotic activator by effecting cytochrome C release. After 48 h
it was significantly up-regulated in all E. coli K12 stimulated
samples while showing lower expression in all MAH infected
MDMs (P,0.001, unpaired t test). With special interest we
observed significant up-regulation of the negative regulator of
TLR signalling IRAK3 in all MAH infected MDMs compared to
E. coli K12 stimulation at 6 h p.i. (P,0.05, unpaired t test).
Generally, we did not observe pronounced MAH strain specific
differences in our infection experiments. But we realised with
particular interest the consistent dysregulation of leukotriene A4
hydrolase gene (LTA4H) at 6 h p.i. with the environmental
isolate MAH 2514 compared to the two other strains, which were
isolated from human patients. MAH 2514 caused on average
double expression values in all donors compared to the other
strains (P,0.0001, unpaired t test). But based on the observation
that the investigated MAH strains caused broadly similar MDM
response to infection and to simplify the data, we decided to
consider the medians of log 2 ratios of all MAH strains for further
analysis. The box plots in figure 4 B include the data obtained
from all three infection experiments considering only the three
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PLoS ONE | www.plosone.org 8 May 2011 | Volume 6 | Issue 5 | e20258Figure 2. Regulatory network of MAH infected MDMs deduced from integrated analysis of miRNA-mRNA microarray data. Negatively
correlated miRNA-mRNA interactions were visualised as a network using Cytoscape. This network gives for the first time an theoretical outline of the
concerted action of regulating miRNAs (blue triangles) and their potential target mRNAs (green circles) in mycobacterial infection of human macrophages.
doi:10.1371/journal.pone.0020258.g002
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(corresponding to 1.5-fold change) were considered to be
differentially expressed. We applied the tool KegArray [29] for
pathway analysis of dysregulated genes using the calculated
medians of log 2 ratios (figure 4 B) of up- or down-regulated
genes. This analysis once again showed that MAH infection
induced mainly genes directing survival e.g. IRAK3, BIRC3 or
BCL2 and underlining the up-regulation of NFkB-transcripts e.g.
TNF, IL12, BCL2 or BIRC3. Taken together, six genes (CSF2,
IL7R, IL12B, INHBA, PDGFB and TNF) were identified to be
dysregulated across MAH infection being related to the ‘‘cytokine
cytokine-receptor interaction’’ category of KEGG. IRAK3,
BIRC3 and TNF were dysregulated throughout the entire
infection and were classified into the apoptosis pathway.
MAH infection of MDMs causes concomitant
up-regulation of let-7e and miR-29a targeting key
caspases CASP3 and 7
For validation of miRNA microarrays and to investigate both
the donor and MAH strain specific progress of the infection, we
have applied a miRNA specific qRT-PCR approach, called miR-
Q [30]. The individual response of MDMs isolated from different
donors was studied using the same RNA samples as described for
the mRNA qRT-PCRs by also including the MAH strain 2514 as
well as the non-pathogenic E. coli K12 as a control. For this
purpose, we mainly considered temporally induced miRNAs.
Figure 5 shows the expression of selected miRNAs after infection
with MAH strains as well as E. coli K12. Since the expression of
distinct miRNAs differed only slightly between the three donors
Table 3. Functional enrichment of pathways deduced from integrated miRNA-mRNA analysis.
Functionally enriched Pathways* Potential Target Genes** Potential miRNA regulators*** % of Genes****
Cytokines and Inflammatory Response IL10, IL8 hsa-let-7e, hsa-let-7f, hsa-let-7g, hsa-let-7i, hsa-mir-27a,
hsa-mir-374a, hsa-let-7a, hsa-mir-20a
8
NFkB activation by Nontypeable
Hemophilus influenzae
IL8, MAP2K3 hsa-let-7i, hsa-mir-20a, hsa-let-7a, hsa-let-7g
hsa-let-7f, hsa-let-7e, hsa-mir-21
8
Caspase Cascade in Apoptosis CASP3, CASP6 hsa-let-7i, hsa-let-7e, hsa-let-7f, hsa-let-7g, hsa-let-7a,
hsa-mir-30b, hsa-mir-30c, hsa-mir-185
9
Induction of apoptosis through DR3
and DR4/5 Death Receptors
BID, CASP3, CASP6 hsa-mir-26b, hsa-mir-26a, hsa-let-7i, hsa-let-7e,
hsa-let-7f, hsa-let-7g, hsa-let-7a, hsa-mir-30b,
hsa-mir-30c, hsa-mir-185
11
FAS signaling pathway ( CD95 ) CASP3, CASP6 hsa-let-7i, hsa-let-7e, hsa-let-7f, hsa-let-7g, hsa-let-7a,
hsa-mir-30b, hsa-mir-30c, hsa-mir-185
7
TSP-1 Induced Apoptosis in
Microvascular Endothelial Cell
CASP3, CD36 hsa-let-7i, hsa-let-7e, hsa-let-7f, hsa-let-7g, hsa-let-7a,
hsa-mir-30b, hsa-mir-30c, hsa-mir-423-5p
29
Fc Epsilon Receptor I Signaling
in Mast Cells
PRKCB, SYK hsa-mir-185, hsa-mir-886-5p 7
Selective expression of chemokine
receptors during T-cell polarization
CCR1, CCR7 hsa-mir-185, hsa-mir-423-5p, hsa-let-7g,
hsa-mir-21, hsa-let-7f, hsa-let-7i, hsa-let-7e,
hsa-let-7a, hsa-mir-423-5p
8
*Pathways containing at least 2 differentially expressed genes (or 4%).
**Predicted Target genes showing negatively correlated expression compared with miRNA expression data. Differentially expressed genes with at least 2-fold altered or
temporal expression and regarding expression data of each time point and MAH strain were considered (listed in figure A–C).
***miRNAs predicted to target differentially expressed genes with negatively correlated expression data. Each miRNA is predicted to target at least one of the listed
genes in column 2.
****Percentage of the differentially expressed genes which share a pathway membership with regard to all associated genes according to Reactome/Biocarta and Kegg
pathway databases implemented in Cytoscape 2.7.0.
doi:10.1371/journal.pone.0020258.t003
Figure 3. Temporal CASP3/CASP7 activity upon MAH infection of MDMs. MDMs were infected with bacteria and the luminescence signal
(relative light units, RLU) proportional to the activity of CASP3/CASP7 was measured. Columns represent the mean of quintuplicate measurements
while error bars show the standard deviation. Asterisks indicate statistical significance according to paired t test (***: P,0.001).
doi:10.1371/journal.pone.0020258.g003
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calculate the log 2 ratios of means of all donors relating to each
MAH strain and E. coli K12, respectively. While miR-146a was
induced right after infection and showed slightly increased
expression up to 48 h p.i., no significant differences were observed
dependent on the infectious agent. On the other hand, miR-146b
was first up-regulated after 24 h and showed similar expression
patterns after 48 h. MAH strains caused significantly lower miR-
146b induction (P,0.005, unpaired t test) at both points in time
compared to the E. coli K12 stimulation. MiR-155 was induced by
all bacteria (figure 5); while at 6 and 24 h p.i. E. coli K12
stimulation caused a significantly higher expression of miR-155
compared to MAH strains (P,0.04, unpaired t test). Interestingly,
MDMs infected with MAH strains showed increased miR-29a
expression after 48 h. As shown in figure 5, the E. coli K12
stimulated MDMs showed the same miR-29a expression level at
48 h compared to 24 h after infection. MAH strains, however,
caused significantly increased expression of miR-29a only at the
end of the infection experiment (P#0.0002, unpaired t test).
Progressing course of infection caused a clear induction of let-7e in
all samples, but MAH infected MDMs exhibited significantly
lower expression compared to the E. coli K12 stimulation
(P,0.005, unpaired t test). With particular interest we observed
significant up-regulation of miR-886-5p only in MAH infected
MDMs at 48 h compared to the control (P#0.0255, unpaired t
test). A significant difference between all MAH infected MDMs
and E. coli K12 stimulation was only observed at this time point
(figure 5).
For the integrated miRNA-mRNA-analysis of the qRT-PCR
data, we have performed a MAGIA analysis of corresponding log
2 ratios shown in the heat maps in figure 4 A and all log 2 ratios of
miRNAs shown in figure 5. Figure 6 shows the Cytoscape network
generated from only negatively correlated MAGIA predicted
interactions. Network analysis showed IRAK3 and BAX to be two
target genes of miR-886-5p both exhibiting significant down-
regulation in MAH infection at 48 h compared to 24 h.
RNAhybrid analysis [31] of potential interactions between the
miRNA and the 39 UTR revealed three potential target sites with
mfe,220 kcal/mol within the 39 UTR of IRAK3 and five
possible interactions between miR-886-5p and BAX including one
significant interaction (P,0.04; data not shown). Consistently,
IRAK3 expression was decreased at 48 h after MAH infection
significantly compared to 24 h (P,0.05; figure 4 B). Network
analysis showed mutual targeting of TP53 by let-7e and miR-886-
5p each possessing five possible target sites with mfe,220 kcal/
mol including two significant interactions of let-7e (P,0.033; data
not shown) calculated by RNAhybrid. The network demonstrated
that the platelet-derived growth factor beta (PDGFB or PDGF2) is
mutually targeted by two miRNAs, miR-29a and let-7e being both
up-regulated in late stage of MAH infection. Interestingly, MDMs
infected with MAH strains exhibited a significant decrease of
PDGFB expression after 24 h and 48 h compared to 6 h,
respectively (P,0.026, unpaired t test). A more in-depth analysis
of the interactions of these miRNAs and the 39 UTR of PDGFB
based on RNAhybrid calculation predicted four possible target
sites of let-7e possessing a minimum free energy (mfe) of less than
220 kcal/mol and including one significant site (P,0.05; data not
shown). Also one significant site of interaction between PDGFB
and miR-29a was calculated possessing an mfe=224.5 kcal/mol
and P#0.0243 (data not shown). The target site analysis using the
RNAhybrid algorithm pointed out five possible interactions
between let-7e and the 39 UTR of IL10, all possessing no
significant P values and higher mfe than 220 kcal/mol (data not
shown). The calculated network in figure 6 moreover showed an
interaction between let-7e and BCL2L1, which showed signifi-
cantly decreased expression after E. coli K12 stimulation compared
to the MAH infected MDMs at 24 h as well as 48 h. RNAhybrid
analysis also revealed the identification of three target sites of let-7e
within the 39 UTR possessing an mfe,220 kcal/mol while two
were predicted to be significant interactions (P,0.0064 and
P,0.037; data not shown).
Surprisingly, the network generated from the qRT-PCR data
revealed CASP3 and CASP7 to be targeted by let-7e and miR-29a
both possessing increased expression only in MAH infected
MDMs at 48 h compared to 24 h. As shown in figure 7 A,
RNAhybrid analysis revealed one potential target site of let-7e
with mfe,220 kcal/mol within the 39 UTR of CASP3 and two
possible target sites of miR-29a within the 39 UTR of CASP7
(P,0.05). To confirm functional relevance of presented networks
and to address the hypothesis that the observed CASP3/7 down-
regulation is directed by these two miRNAs, we performed
reporter gene assays by fusing the 39 UTRs of CASP3 and CASP7
into the Gaussia luciferase (Luc Gaussia), respectively. 8 h after co-
transfection of let-7e mimic miRNA together with CASP3 reporter
into HeLa cells significant (P,0.01, paired t test) and 35%
decreased normalised luciferase activity (Luc Gaussia : Luc Cypridina)
was measured compared to the non-sense miRNA transfected
controls (figure 7 B). Sustained down-regulation (25%) was also
detected at 24 h post transfection. Accordingly, HeLa cells co-
transfected with miR-29a mimic miRNA together with CASP7
reporter showed significant (P,0.01, paired t test) and 25%
decreased normalised luciferase activity after 8 h compared to the
non-sense miRNA transfected controls (figure 7 B). Sustained
down-regulation (27%) was also detected at 24 h post transfection.
This approach showed that key regulators of apoptosis CASP3 and
7 are under the control of let-7e and miR-29a, respectively
underlining the functional relevance of our strategy.
Discussion
MAH represents a very diverse group of mycobacteria. Even
within the same strain phenotypic variation occurs and is reflected
by the appearance of different colony morphotypes. Different
MAH strains and even different morphotypes of the same strain
exhibit deviating virulence [10]. MAH occurs ubiquitously and has
been isolated not only from patients but also from water, soil, dust,
pig and other life stock [32]. The route of infection so far is
unknown. A relatively high degree of genetic variability has been
reported [33] but no correlation relating genetic traits or habitat
on the one side and virulence on the other side has so far been
established. Furthermore, there is no experimental evidence that
environmental strains are less pathogenic than clinical strains. In
order to take account of the diversity of MAH strains and to obtain
Figure 4. mRNA expression data of MAH infected MDMs after qRT-PCR analysis. Columns in panel A represent the individual expression of
MDMs from three different human donors (Donor 1–3) infected with MAH strains 2514, 10091/06 and 104 as well as E. coli K12 as a control. Colours
represent log 2 ratios of the means of triplicate measurements of infected cells versus the non-infected control according to the scales shown below.
The box plots in panel B include the data obtained from all three infection experiments considering all three MAH strains. Log 2 ratios below 20.585
and above 0.585 (corresponding to 1.5-fold change) are indicated by the green and red dashed lines and were considered to reflect differential
expression.
doi:10.1371/journal.pone.0020258.g004
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MAH infection, we included in our study three MAH strains
isolated from different settings. Strains 104 and 10091/06 were
isolated form an HIV patient and a child with lymphadenitis,
respectively, while strain 2514 was isolated from water.
In general, we deduce from our microarray data that both
MAH strains isolated from human patients (10091/06 and 104)
behave similar to other virulent mycobacteria independently from
the pathogenesis of disease they caused in patients. In this regard
we speculate that the pathogenesis of MAH-associated-diseases is
rather a consequence of the immune conditions of patients than
genetic differences of MAH determining pathogenicity. To give an
example, two important members of the signalling events of host
cells encountering pathogens are signal transducer and activator of
transcription 1-alpha/beta (STAT1) and IFNGR1, which were
timely regulated according to the expression data presented here
(figure 1B, figure 4). It has been shown that pathogenic M. avium
suppress IFNG and Jak/STAT signalling by decreasing levels of
IFNGRs [34], which consequently reduced STAT1 phosphoryla-
tion and activity. This provides further indications that both
studied MAH strains possess virulent characteristics by orches-
trating diminished IFNG signalling. Gehring and colleagues
moreover reported that the 19-kDa lipoprotein of M. tuberculosis
inhibits IFNG-induced expression of FCGR1A [35]. They
proposed that M. tuberculosis inhibits IFNGR signalling in human
macrophages through 19-kDa lipoprotein activation of TLR2.
Our data agrees with these observations since TLR2 was up-
regulated after infection of MAH strains 2.6-fold after 24 h
(figure 1 B). TLRs are receptors recognising pathogen-associated
molecular patterns (PAMPs). Successive stimulation typically
induces NFkB and MAPK pathways resulting in the production
of pro-inflammatory cytokines, such as IL1B and TNF, finally
inducing a T-cell response. Viable mycobacteria or lipopolysac-
charide (LPS) induce the maturation of DCs probably through
TLR2- and TLR4-dependent signalling pathways [36]. The
protective effect of TLR2 signalling in mycobacterial infections
was commonly proposed. On the other hand, TLR4 deficient
mice were shown to behave like the wildtype in a M. avium
infection model [37]. The observed TLR2 up-regulation and
thereby mediated pro-inflammatory response supports the pro-
posed major importance of TLR2 response in M. avium infection.
Concomitant down-regulation of TLR4 indicates a subordinate
role of TLR4 associated inflammatory response to MAH.
Upon infection, macrophages are functionally polarised into M1
and M2. Bacterial pathogens trigger the transcription of a set of
genes belonging to the M1 program known as ‘‘common host
response’’. Progressive M1 polarisation, however, leads to
excessive production of pro-inflammatory cytokines and results
in tissue damage and recruitment of defence cells [25]. Pathogenic
but not non-pathogenic mycobacteria have evolved mechanisms to
suppress those signalling cascades (MAPK, Jak/STAT), which
result in cytokine-induced immune response. Our data reflect both
the expression of genes involved in protective immunity as well as
inhibitors of activated macrophages. For example, IL1B has a
protective role in immunity to tuberculosis and leads to the
production of NO [38,39]. IL10 blocks the pro-inflammatory
cytokine production and reduces MHCII expression, which is
required for antigen presentation. It furthermore inhibits activated
DCs and macrophages [38]. Interestingly, M2 macrophages
(derived from direct tumor cell contact and IL4, IL10 and IL13
exposure) drive a Th2 response resulting in increased expression of
anti-inflammatory cytokines and down-regulation of pro-inflam-
matory mediators. M2 macrophages are characterised by IL4 and
IL10 production, TGFB expression, and their involvement in
tissue remodelling via VEGF and MMP expression [40].
Therefore, our data reflected an M2-like expression profile, which
induces a Th2 response in order to evade the immune response
and counteract inflammation. In this regard the early secreted
antigenic target protein-6 (ESAT-6) from M. tuberculosis was
reported to directly interfere with M1 polarisation by e.g.
inhibiting NFkB activation [25]. On the other hand, our data
pointed out the up-regulation of genes such as TNF, IL1B and the
chemokine ligand CXCL10 that represent an M1 macrophage
polarisation. The mixed M1/M2 activation represented by our
data may be based on an initial M1 polarisation following the
‘‘common host response’’, which is successively manipulated into
M2 by ESAT-6-like proteins of MAH. In this context, Gey Van
Pittius and colleagues have reported that multiple duplicates of the
ESAT-6 gene cluster were found in M. tuberculosis and were
conserved also in M. leprae, M. bovis and M. avium [41].
For validation of our microarray experiments we performed
qRT-PCRs by including an environmental MAH isolate (2514) as
Figure 6. Regulatory network of MAH infected MDMs deduced
from integrated analysis of miRNA-mRNA expression after
qRT-PCR experiments. Negatively correlated miRNA-mRNA interac-
tions were visualised as a network using Cytoscape. Lines represent
predicted interactions considering negatively correlating miRNA (blue
triangles) and mRNA (green circles) expression data.
doi:10.1371/journal.pone.0020258.g006
Figure 5. miRNA expression data of MAH infected MDMs after miRNA specific qRT-PCR analysis. The columns show the mean
expression of distinct miRNAs from all three donors each measured in triplicates while error bars show the standard deviation. The calculated log 2
ratios of means of all donors relating to each MAH strain and E. coli K12 are shown, respectively. Asterisks indicate statistical significance according to
unpaired t test (*: P,0.05; **: P,0.01; ***: P,0.001).
doi:10.1371/journal.pone.0020258.g005
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observe pronounced MAH strain specific response of host
macrophages. This underlines our hypothesis that pathogenesis
of disease is likely to be determined by the host than the MAH
strain and its origin of isolation. However, LTA4H constituted an
exception. LTA4H catalyses the synthesis of the pro-inflammatory
Figure 7. let-7e and miR-29a target CASP3 and CASP7, respectively. Down-regulation of CASP3 and CASP7 by let-7e and miR-29a was
verified using reporter gene assays. Panel A: Identified target sites between miRNAs and both caspases were analysed using RNAhybrid. Panel B: HeLa
cells were co-transfected with miRNA mimics and plasmids harbouring the 39 UTR of CASP3 and 7, respectively. Relative luciferase activity (Luc Gaussia :
Luc Cypridina) was determined respective to the a non-sense miRNA mimics serving as a control. The columns show means of normalised luciferase
activity each measured in triplicates while error bars show the standard deviation. Asterisks indicate statistical significance between miRNA treated
samples and non-sense miRNA treated controls according to paired t test (**: P,0.01).
doi:10.1371/journal.pone.0020258.g007
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tant of polymorphonuclear leukocytes. One could speculate
whether the water isolate MAH 2514 causes a preterm LTB4
derived inflammatory response compared to both MAH strains
isolated from human patients. Our microarray experiments
showed early PLCG2 down-regulation. PLCG2 was reported to
be activated after infection with attenuated M. tuberculosis strains
regulating several functions of neutrophils such as generation of
reactive oxygen intermediates (ROI) and induction of MAPK-
signalling [42]. Koul et al. moreover assumed that virulent M.
tuberculosis may inhibit PLCG2 tyrosine phosphorylation resulting
in down-regulation of MAPK signalling pathways. Interestingly,
our microarray data showed direct transcriptional down-regula-
tion of PLCG2 by both MAH strains probably leading to a similar
outcome as hypothesised above. But consecutive qRT-PCRs
(figure 4 A) rejected this hypothesis, since down-regulation of
PLCG2 was also observed in the control MDMs infected with the
non-pathogenic E. coli K12. Early transcriptional down-regulation
of PLCG2 in host cells may constitute a general negative feedback
loop avoiding excessive release of pro-inflammatory cytokines. In
contrast to lacking MAH strain specific differences we observed
donor specific variations of host response. These inter-individual
differences call the use of cell lines such as THP-1, U937 or RAW
264.7 presented in several studies into question. Suchlike
immortalised macrophage-like cell lines are altered especially with
respect to cell survival. In our opinion, the use of primary
macrophages derived from peripheral blood monocytes generates
a more representative model of the host. Based on the observation
of donor-specific differences, we suggest the randomisation of
infection experiments using MDMs from different donors as
presented in our study.
This is the first study investigating the macrophage miRNA-
response to mycobacterial infections. Our study showed induction
of renowned regulators of innate immunity miR-155 and miR-146
that modulate e.g. TLR signalling or cytokine response. As
mentioned above, miR-146 targets TLR signalling molecules like
TRAF6 [18], which is involved in TLR4 mediated inflammatory
response. This is in consistence with our mRNA microarray data
showing decreased TRAF6 levels in progressing infection (data not
shown). As described in the introduction, these miRNAs are
thought to direct a sharp macrophage immune response to
antagonise pathogens but avoiding tissue damage by a negative
feedback loop. However, three miRNAs (let-7e, miR-29a and
miR-886-5p) were specifically up-regulated after mycobacterial
infection at 48 h compared to 24 h. The here introduced
approach of miRNA-mRNA-analysis is based on integration of
expression data and target analysis and provides a theoretical
concept for unveiling a new regulative layer, how distinct
mycobacteria could alter host cell response to infection. To give
an example, miR-886-5p was significantly up-regulated only at
48 h compared to E. coli K12 stimulation and we determined a
potential interaction of miR-886-5p and IRAK3. Interestingly, the
M. tuberculosis Man-LAM was reported to induce IRAK3
expression in macrophages by inhibiting IRAK-TRAF6 interac-
tion [43]. While miR-886-5p expression was increased at 48 h, the
IRAK3 expression was negatively correlated. Man-LAMs of
distinct mycobacteria may cause differed IRAK3 response. It will
be of interest, whether the mycobacterial mediated alteration of
IRAK3 response is under the control of miR-886-5p. Our future
study will concentrate on the question whether Man-LAMs of
MAC are able to cause altered IRAK3 response of macrophages.
The miR-29 family was shown to be transcriptionally repressed by
hedgehog, NFkB and c-Myc [44]. Interestingly, the protein
ESAT-6 from M. tuberculosis was shown to down-regulate the
expression of c-Myc in an ERK1/2-dependent manner [45] and
as mentioned above to drive an M2 polarisation. It would be
interesting to address the question if mycobacteria are able to
modulate host inflammatory response via the c-Myc mediated
miR-29 pathway. MiR-29a was shown to directly target negative
regulators of Wnt signalling [46]. On the other hand, Wnt is
known to trigger macrophage inflammatory response [47]. As
indicated above, we hypothesise an ESAT-6 dependent c-Myc-
miR-29 axis, which may determine macrophage inflammatory
response through modulation of Wnt signalling upon mycobacte-
rial infection. Our network analysis showed mutual targeting of
PDGFB by let-7e and miR-29a. PDGFB was shown to be one of
the key molecules enabling the entry of an intracellular pathogen
Chlamydia pneumoniae into human cells [48]. A PDGFB mediated
uptake of mycobacteria has not been reported before; however,
miR-29a/let-7e mediated down-regulation of PDGFB may be part
of a protective mechanism of the host cell. Moreover, it was
reported that CD44 enables binding of M. tuberculosis and mediates
mycobacterial phagocytosis, macrophage recruitment and pro-
motes protective immunity [49]. It will be to clarify whether
pathogenic mycobacteria like M. tuberculosis are able to alter the
CD44 induced processes via altering the let-7e expression.
Recently, the let-7 family as well as miR-886-5p were shown to
regulate apoptosis of cancer cells by targeting BCL2L1 and BAX,
respectively [50,51]. As introduced, it was also shown that let-7a
targets the executioner of apoptosis CASP3 [17]. Both the
extrinsic and the intrinsic pathway of apoptotic cell death involve
the activation of caspase cascade and degradation of genomic
DNA. Apoptosis is controlled on many levels, and this involves the
BCL2 family proteins, consisting of members with pro- and anti-
apoptotic character. These regulate the release of cytochrome C
(intrinsic pathway).Virulent strains of M. tuberculosis for example
induce much lower levels of apoptosis than attenuated strains [52].
Apoptosis is an evolutionary old strategy of metazoans to eliminate
pathogens by the loss of the infected cells to the benefit of the
organism. It is assumed that virulent mycobacteria are able to
inhibit apoptosis e.g. by altering the BCL2 pathway [53] as a
possible mechanism to avoid host defence. On the other hand,
induction of apoptosis in M. avium-infected macrophages limits
bacterial viability based on the assumption that apoptosis acts as
host defence mechanism [54]. However, the published data
concerning the fate of infected cells is inconsistent. It was reported
that intracellularly replicating M. avium strains induce apoptosis
but other strains that are unable to multiply in macrophages cause
apoptosis to a minor degree [55]. Many studies showed that
induction of apoptosis by M. avium involves the extrinsic pathway
and is TNF and TNFSF6 dependent. But other pathways
involving ROI, p38 MAPK, apoptosis signal-regulating kinase I
as well as disruption of the mitochondria seem to play a role in M.
avium-induced apoptosis [56]. Programmed cell death in U937
cells infected with M. avium strain 101 was induced by 14-fold
reduced expression of the anti-apoptopic gene BCL2L1 [14]. Our
qRT-PCR data point out the ability of studied MAH strains to
inhibit apoptosis by transcriptional down-regulation of pro-
apoptotic members of the BCL2 family. In this context, the
network deduced from both miRNA- as well as mRNA-qRT-PCR
data revealed CASP3 and 7 to be targeted by let-7e and miR-29a,
respectively. As demonstrated by the presented CASP3/CASP7
assays, both caspases possessed decreased activity after 6 h and
24 h p.i. in all samples compared to the non-infected control.
However, sustained and significant diminished caspase activity was
only caused by MAH strains at 48 h p.i. In line with this
observation both miRNAs were up-regulated at 48 h p.i. and we
were able to show that let-7e and miR-29a target both caspases. It
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apoptosis by mycobacteria relies on interplay of concomitant up-
regulation of let-7e and miR-29a targeting key caspases along with
increased expression of miR-886-5p mediating the down-regula-
tion of the apoptotic activator BAX [50].
Taken together, we show for the first time that miRNAs are
specifically induced after mycobacterial infection of human
macrophages compared to E. coli K12 stimulation. We provide a
theoretical concept of gene expression regulation in the host
response to mycobacteria and functional relevance of presented
data is exemplified by the let-7e/miR-29a mediated down-
regulation of CASP3 and CASP7. We furthermore point out that
MAH-induced up-regulation of miRNA expression interferes with
regulation of apoptosis. Since various intracellular bacterial
pathogens are able to manipulate host apoptotic pathways
differently, our ongoing work will address the question if different
agents cause a specific miRNA response.
Materials and Methods
Bacterial strains and cultivation
MAH strain 104 is an isolate from an AIDS patient [21]. MAH
strain 10091/06 was isolated from the lymph node of an infected
child. Both strains were kindly provided by Dr. Elvira Richter
from the National Reference Center for mycobacteria in Borstel,
Germany. MAH strain 2514 was isolated from drinking water and
was kindly provided by Prof. Schulze-Ro ¨bbecke, University
Hospital Du ¨sseldorf, Germany. E. coli K12 as well as mycobacteria
were grown as described before [57].
Infection of human monocyte derived macrophages
Monocytes were isolated from buffy coats from healthy donors
using Ficoll-Paque
TM Plus (GE Healthcare) and Percoll
TM (GE
Healthcare) gradient centrifugation according to the manufactur-
er’s recommendations. After the Percoll gradient centrifugation,
the monocytes were washed twice with PBS (140 mM NaCl,
16.0 mM Na2HPO4, 2.00 mM KH2PO4, 3.75 mM KCl, pH 7.4)
and resuspended in IMDM medium (PAA) with 3% human AB
serum. The cells were counted and 6 to 10 million cells were
seeded per 25 cm
2 cell culture flask (TPP) and incubated at 37uC
and in 5% CO2. Cells were allowed to adhere overnight and the
non-adherent cells were then removed by sound rinsing of the cell
layer using IMDM medium.
To quantify the proportion of monocytes as well as MDMs in
the adherent cell fraction, the cells in one of the flasks were
detached by addition of 20 ml PBS with 5 mM EDTA, incubation
at 4uC for 1 to 2 h and scraping off. After centrifugation the cells
were resuspended in PBS and the percentage of monocytes was
determined by FACS analysis using a mouse anti-human CD14
antibody (monoclonal antibody MEM-18, Immuno Tools) and a
goat anti-mouse FITC-conjugated secondary antibody (Immuno-
Tools). A mouse IgG1 control (monoclonal antibody 203, Immuno
Tools) was included to assess non-specific antibody binding. FACS
analysis was performed using the BD FACScalibur cytometer (BD
Biosciences).
The cells in the remaining flasks were allowed to differentiate
during three days in IMDM with 3% AB serum and then infected
for 4 h with MAH 104, MAH 10091/06, MAH 2514 or E. coli
K12 DH5a at a multiplicity of infection (MOI) of 25 as described
earlier with following modifications [58]. One flask was not
inoculated and served as negative control. Non-phagocytosed
bacteria were removed by washing and treating the cell layer with
200 mg/ml amikacin for 2 h and final incubation in medium
containing 5 mg/ml amikacin. Samples were taken for RNA
isolation after 6 h, 24 h and 48 h p.i. All strains were used to
perform three independent infection experiments applying MDMs
from different human donors. Total RNA was isolated from
infected as well as non-infected adherent cells using the miRVana
miRNA Isolation Kit (Life Technologies) as described earlier [59].
The described procedure was performed in triplicate using the
buffy coats from three independent healthy donors.
Apoptosis of monocytes was monitored by measurement of
activity of caspases 3 and 7 using the Caspase-GloH 3/7 Assay
System (Promega) according to the manufacturer’s protocol.
RNA amplification
In order to generate sufficient amounts of RNA for cDNA
microarray experiments, pools of RNA (from triplicate infection
experiments) were amplified using the MessageAmp II aRNA
Amplification Kit (Life Technologies) according to the manufac-
turer’s instructions. To compensate the donor based biological
variance, pools of total RNA from three independent infection
experiments were prepared for MAH strains 104 and 10091/06
and non-infected controls relating to each point in time (6, 24 and
48 h p.i.). Each infection experiment was performed with primary
monocytes derived from the buffy coats of three different human
donors. The procedure included a reverse transcription using 1 mg
of pooled total RNA and a T7 oligo (dT) primer to synthesise first
strand cDNA containing a T7 promoter sequence. The cDNA is
subsequently converted into double stranded DNA (dsDNA) by
second strand synthesis. After degradation of RNA and cDNA
purification, in vitro transcription (IVT) was employed to generate
antisense amplified RNA (aRNA). After a final purification step
quality and quantity of aRNA samples were assessed using Agilent
2100 Bioanalyzer and RNA Nano Chips (Agilent) and Nanodrop
1000 Spectrophotometer (Thermo Scientific).
cDNA microarray analysis
Experiments were performed using the PIQOR
TM Immunology
Microarray Kit, human, antisense (Miltenyi Biotec). The micro-
array carries 1076 cDNA probes, which are 200–400 bp in length
and spotted in quadruplicate. PIQOR
TM Immunology Micro-
arrays include key genes for immune response, cell death,
extracellular matrix, and signal transduction as well as 6
housekeeping genes and 6 controls. All hybridisations were
accomplished using the generated aRNA samples as two colour
experiments hybridising two samples labelled with different
fluorescent dyes to a single microarray. aRNA was converted into
cDNA and fluorescently labelled using the SuperScript
TM Plus
Indirect cDNA Labelling System (Life Technologies) and Alexa
FluorH Dyes. 15 mg aRNA and anchored oligo (dT) were used for
reverse transcription according to the manufacturer’s protocol.
Sample cDNA (infected) was fluorescently labelled with Alexa
FluorH 647 (red emission), while the control (non-infected) was
labelled with Alexa FluorH 555 (green emission). Dye-dependent
bias was evaluated by a dye swap experiment. Automated
hybridisation and washings were carried out in the aHyb
TM
Hybridisation Station (Miltenyi Biotec). Buffers for pre-hybridisa-
tion, hybridisation and wash were supplied with the PIQOR
TM
Microarray Kit (Miltenyi Biotec) and protocols were followed
according to the manufacturer’s instructions. Briefly, initial pre-
treatment was performed at 75uC for 2 min using 50% formamide
in bi-distilled water followed by 2 wash cycles with bi-distilled
water at 75uC for 2 min; pre-hybridisation was performed at 63uC
for 5 min and fluorescently labelled samples were hybridised for
16 hours at 63uC. Finally the slides were successively washed for
1 minute (2 cycles) with the supplied wash buffer 1 and 2 at 50uC
and 35uC, respectively. Afterwards, slides were removed from the
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Finally, the slides were dried by brief centrifugation. The
microarrays were scanned at 10 mm resolution using a GenePix
4000B scanner (Molecular Devices). Microarray image analysis
and ratio-based normalisation of the microarray data was
conducted using the software package GenePix Pro 6.1 (Molecular
Devices). In order to avoid analysis of weakly and unexpressed
transcripts, criteria were defined to select genes for further analysis
based on background-subtracted signal intensity, signal to noise
ratio and spot diameter. After assessment of reproducibility and
evaluation of dye swap experiments replicate microarray data was
combined by calculating the mean of respective log 2 ratios for
subsequent analysis. Data analysis was performed using the Acuity
4.0 software package (Molecular Devices). Discrimination of
expression profiles reflecting temporal regulation during the
course of infection was assessed by statistical analysis of different
time points after infection using ANOVA. The data was organised
using cluster analysis and displayed as individual heatmaps
according to median log 2 ratios of all time points.
MIAME-compliant data of all performed microarrays consid-
ering the applied platforms as well as processed and raw sample
data were submitted to the NCBI GEO repository [60] and
accession-numbers were assigned (series: GSE27100; cDNA
microarrays: GSM671371-76).
Quantification of mRNA
Quantification of gene expression was performed by means of
qRT-PCR as described earlier with few modifications [61]. Firstly,
1 mg of total RNA was reverse-transcribed using the RevertAid
TM
M-MuLV Reverse Transcriptase (Fermentas GmbH) in 20 ml total
volume using random Hexamers. SYBR Green qPCR was
performed using the SensiMix DNA Kit (Quantace Ltd.) and
0.2 mM of gene specific primers (table S3). The first step of
amplification was denaturation at 95uC for 10 min, followed by 40
cycles with 15 s at 95uC, 10 s at 60uC and 20 s at 72uC. The
fluorescence signal was acquired at 72uC. Melting curve analysis
allowed testing for specificity of qRT-PCR. The optimal annealing
temperatures of all primers (table S3) were first evaluated
performing gradient qRT-PCRs followed by sequencing of
purified amplicons. Absolute quantification was performed by
converting the Ct values into fg of the specific amplicon per qRT-
PCR reaction using a calibration curve, which was established by
serial dilutions of the corresponding PCR product. Gene
expression was quantified by triplicate measurements of 1 ml 1:5
diluted cDNA in 10 ml final reaction volume. All reactions were
run in the StepOnePlus
TM Real-Time PCR System (Life
Technologies). Normalisation of expression data was performed
using the geNorm algorithm [62] that is based on calculation of
the geometric means of several housekeeping genes (in this study
we used 18S rRNA, GAPDH, and ACTB all possessing stable
expression). The relative gene expression was obtained by
calculating the ratios of absolute quantification values and
normalisation factors provided by geNorm. Subsequent heatmap
analysis was performed using the MultiExperiment Viewer (MeV)
from the TM4 software package [63]. For this purpose, the log 2
ratio of means (triplicate qRT-PCR measurements) of infected
samples and non-infected controls were calculated and were
subjected to the MeV analysis. Independent heatmaps were
created for every point of sampling (6, 24 and 48 h p.i.).
miRNA microarray analysis
MiRNA expression in infected human monocytes was discov-
ered using the miRCURY LNA
TM miRNA Array kit v. 10.0
(Exiqon) with the miRCURY LNA
TM miRNA Array Power
Labeling kit (Exiqon). One microarray consists of eight sub-arrays
composed of tm-normalised capture probes complementary to
mature miRNAs in four replicates. In order to balance possible
biological variation, hybridisations were performed using pooled
total RNA samples. For this purpose, pools of total RNA from
three independent infection experiments were prepared for both
MAH strains (104 and 10091/06) and non-infected controls
relating to each point in time (6, 24 and 48 h p.i.). Each infection
experiment was performed with MDMs of individual human
donors. All microarray experiments were realised as two colour
experiments hybridising two samples labelled with different
fluorescent dyes to a single array. Our general internal laboratory
convention (except of dye swap experiments) implied that samples
(RNA from infected cells) were labelled always with Hy5, while the
control (RNA from non-infected cells) was labelled with Hy3. Fully
automated hybridisation and washings were carried out in the
aHyb
TM Hybridsation Station (Miltenyi Biotec). Buffers for pre-
hybridisation, hybridisation and washes were supplied with the
miRCURY LNA
TM miRNA Array kit. Slides were first pre-
hybridised at 56uC for 5 min and fluorescently labelled samples
were hybridised for 16 hours at 56uC. Afterwards, the slides were
washed twice for 1 minute with the supplied wash buffer A at
56uC followed by two successive washes at 23uC using wash
buffers B and C, respectively. Afterwards, slides were removed
from the hybridisation station and dipped in bi-distilled water and
dried by brief centrifugation. Image acquisition and data analysis
was performed as described above.
MIAME-compliant data of all performed microarrays consid-
ering the applied platforms as well as processed and raw sample
data were submitted to the NCBI GEO repository [60] and
accession-numbers were assigned (series: GSE27100; miRNA
microarrays: GSM669466-71).
Quantification of miRNA
The quantification of miRNA expression in individual samples
was carried out by means of a miRNA specific qRT-PCR
approach called miR-Q as described earlier [30] using the
oligonucleotides in table S3. MiRNA quantification was per-
formed by triplicate measurements for each sample, compared
with a calibration curve established by reverse transcription of
serially diluted amounts of the particular synthetic miRNA in the
presence of 50 ng bacterial total RNA. The RT reaction of non-
spiked bacterial total RNA samples and no template controls were
used as negative controls. All reactions were run in the
StepOnePlus
TM Real-Time PCR System (Life Technologies).
Normalisation of expression data was performed using the
geNorm algorithm as described above. The geometric means of
three miRNAs (miR-16, miR-21 and miR-24), which showed
stable expression on miRNA microarrays was used for calculation
of the normalisation factor. The relative gene expression was
obtained by calculating the ratios of absolute quantification values
and normalisation factors provided by geNorm.
Transfection and reporter gene assays
The human cervix carcinoma cell line HeLa (ATCC No. CCL-
2) was maintained in RPMI 1640 (Biochrom AG) supplemented
with 10% fetal bovine serum superior (Biochrom AG) and 10 mg/
ml Gentamicin (Biochrom AG) and passaged twice weekly.
Cultivation of cells was performed in 75 cm
2 flasks (Greiner Bio-
One GmbH) at 37uC and 5% CO2. HeLa cells were transfected
using the Nucleofector Technology (Lonza AG). Nucleofection
was performed using 5610
5–1610
6 HeLa using 0.9–1.8 mg
reporter plasmid (pTK-Gluc derivatives, NEB GmbH), 100–
200 ng normalisation plasmid (pTK-Cluc, NEB GmbH) and
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instructions.
For generation of reporter plasmids, the 39 UTRs of human
CASP3 and 7 were amplified using the oligonucleotides
NotIhCASP3-3UTRf, XhoIhCASP3-3UTRr, NotIhCASP7-
3UTRf and XhoIhCASP7-3UTRr (table S3). The amplicons
were cloned in pTK-Gluc (NEB GmbH) using the restriction
enzymes NotI and XhoI (NEB GmbH). 100 ng of linearised pTK-
Gluc and 50 ng of digested 39 UTR were ligated in 20 ml total
volume using T4 DNA Ligase (NEB GmbH) for 30 min at 22uC
followed by heat inactivation at 65uC for 10 min. E. coli K12 were
transformed and positive clones harbouring the 39 UTRs of
CASP3 and CASP7 were selected and sequenced, respectively.
Endotoxin-free reporter plasmids (pTKGhCASP3 and
pTKGhCASP7) were produced for transfection using NucleoBond
Xtra Midi Plus EF (Macherey-Nagel GmbH & Co. KG). The
reporter plasmids pTKGhCASP3 or pTKGhCASP7 were co-
transfected with Pre-miR miRNA Precursors hsa-let-7e or hsa-
miR-29a (Life Technologies), respectively. The non-sense miRNA
Pre-miR miRNA Precursor Negative Control #1 (Life technol-
ogies) was used as a control for specificity of interaction. Detection
of Gaussia and Cypridina Luciferase activity serving as experi-
mental and control reporter genes was performed using the Biolux
Assay Kits (NEB GmbH). Supernatants of adherent cells were
taken at 8 and 24 h post Nucleofection. Luciferase measurement
of three independent transfection experiments was performed in
triplicate using 15 ml of the supernatant according to the
manufacturer’s protocol. Luciferase activity was determined in
white 96 well microplates (Greiner Bio-One GmbH) using the
automated luminometer FLUOstar OPTIMA (BMG Labtech).
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